Metabolism Prescription Combined with Metformin in the Intervention of Type 2 Diabetes Mellitus Combined with Obesity: a Multicenter Randomized Controlled Double-Blind Clinical Study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000003636

Enrollment

Unknown

Registered

2020-08-22

Start date

2020-10-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus combined with Obesity

Interventions

2:Placebo granules plus metformin

1:Metabolism Recipe Granules plus Metformin

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Between 18-65 years old; meet the diagnostic criteria for type 2 diabetes combined with obesity; willing to cooperate with this trial treatment plan and sign an informed consent form.

Exclusion criteria

Exclusion criteria: Pregnant or lactating women; those who are allergic to acupoint embedding therapy; those who have serious complications such as heart, liver, kidney, and brain; and those with other serious primary diseases; and those with mental illness.

Design outcomes

Primary

Measure	Time frame
weight;Glycated hemoglobin;	—

Secondary

Measure	Time frame
C Peptides;Blood lipids;Inflammatory factors;MRI measurement of subcutaneous and visceral fat content in the upper abdomen;insulin;Fasting blood glucose;	—

Countries

China

Contacts

Public ContactZhou Shigao

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

dr-shigao@163.com+86 18917763108

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026